Last updated on June 2017

Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation


Brief description of study

In this open-label, prospective, randomized pilot study, patients who develop atrial fibrillation after isolated coronary artery bypass grafting surgery will be identified. Patients with persistent atrial fibrillation (>12 hours) or recurrent sustained atrial fibrillation (>2 episodes of atrial fibrillation lasting longer than 30 minutes) will be candidates for inclusion. Upon meeting study inclusion and exclusion criteria, and after informed consent, patients will be randomized to either the standard of care (warfarin per protocol) or apixaban arms of the trial. Routine postoperative care after CABG will occur in both groups. Upon discharge, anticoagulation in both groups will be managed by the anticoagulation clinic. Patients will be followed for 30 days after surgery.

Clinical Study Identifier: NCT02889562

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Cornelius Dyke, MD

Sanford Health
Fargo, ND United States
  Connect »